Stock A009730 IREM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights IREM Co.,Ltd.

Equities

A009730

KR7009730003

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
1,812 KRW -0.82% Intraday chart for IREM Co.,Ltd. +1.57% -36.86%
Jan. 31 KOSSEN Co., Ltd. completed the acquisition of Super Deck Business Division of Kosteel Co.,Ltd. from Kosteel Co.,Ltd. CI
Jan. 02 KOSSEN Co., Ltd. announced that it expects to receive KRW 7 billion in funding CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KOSSEN Co., Ltd. completed the acquisition of Super Deck Business Division of Kosteel Co.,Ltd. from Kosteel Co.,Ltd.
CI
KOSSEN Co., Ltd. agreed to acquire Super Deck Business Division of Kosteel Co.,Ltd. from Kosteel Co.,Ltd. for KRW 45 billion.
CI
KOSSEN Co., Ltd. cancelled the acquisition of additional 14.57% stake in Biogenicskorea Co., Ltd. from a group of sellers.
CI
KOSSEN Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
SD Biotechnologies Co., Ltd. agreed to acquire a 38.636208% stake in IMMUNOBIOTECH Corp. from KOSSEN Co., Ltd. for KRW 5.3 billion.
CI
KOSSEN Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Codenature Inc. agreed to acquire 30.1% stake in Biogenicskorea Co., Ltd. from KOSSEN Co., Ltd. for KRW 10.4 billion
CI
KOSSEN Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
KOSSEN Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
KOSSEN Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
KOSSEN Co., Ltd. cancelled the acquisition of 5.7% stake in Biogenicskorea Co., Ltd. from Korea Securities Finance Corporation.
CI
KOSSEN Co., Ltd. cancelled the acquisition of 30.69% stake in Biogenicskorea Co., Ltd. from a group of sellers
CI
KOSSEN Co., Ltd. completed the acquisition of 15.6% stake in MIZLINE Co., Ltd.
CI
KOSSEN Co., Ltd. agreed to acquire 15.6% stake in MIZLINE Co., Ltd. for KRW 2 billion.
CI
KOSSEN Co., Ltd. completed the acquisition of Upex-med Co., Ltd. from 73 individuals.
CI
KOSSEN Co., Ltd. agreed to acquire additional 14.57% stake in Biogenicskorea Co., Ltd. from a group of sellers for KRW 13.6 billion.
CI
KOSSEN Co., Ltd. agreed to acquire 5.7% stake in Biogenicskorea Co., Ltd. from Korea Securities Finance Corporation for KRW 5.4 billion.
CI
KOSSEN Co., Ltd. agreed to acquire additional 27.49% stake in Biogenicskorea Co., Ltd. from Wellbiotec Co., Ltd. and others for KRW 25.6 billion.
CI
KOSSEN Co., Ltd. agreed to acquire Upex-med Co., Ltd. from 73 individuals for KRW 13.3 billion.
CI
The Mind Asset Co., Ltd, Youngkwang Network Co., Ltd and SR I&D Co., Ltd acquired 12% stake in KOSSEN Co., Ltd. from Je-Won Lee for KRW 8 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A009730 Stock
  4. News IREM Co.,Ltd.
  5. Highlights